Purchase Order 75N91024P00661
Award Date
9/1/24
Potential Completion Date
8/31/25
Potential Value
$39K
Federal Agency
National Cancer Institute
Awardee
Caerus US 1 Inc.
Ultimate Awardee
Not listed
NAICS Category
541519 - Other Computer Related Services
PSC Category
DA01 - It And Telecom - Business Application/Application Development Support Services (Labor)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10119, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,900.00 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Caerus US 1 Inc., a for-profit organization, for software. The contract has a completion date of October 24, 2024. The award was made on April 25, 2024, and no set-aside was used. Caerus US 1 Inc., operating as Citeline, is a provider of drug, device, company, clinical trial, and market intelligence to federal agencies,...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $233,207.00 firm-fixed-price purchase order to Caerus US 1 Inc. for a renewal license agreement to four of Informa Pharma's publications: Pharmaprojects, Pink Sheet Online, Trial Predict, and Trial Trove. This award, which does not have a set-aside designation, provides Caerus US 1 Inc.'s Citeline division with continued access to these pharmaceutical information...
The federal contract award, valued at $10,743.00, was issued by the National Cancer Institute (NCI) to Certara USA Inc., a leading global technology-enabled drug development and drug safety consultancy, for the procurement of software licenses. The contract is a firm-fixed price purchase order with no set-aside designation and an ultimate completion date of August 13, 2025. Certara USA Inc. has received numerous prime contract awards from the NCI, Food and Drug Administration (FDA), and National...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...
This federal contract award was made by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The award, valued at $1,076,616.60, is for Scientific Support Services for a Medical Officer 9 to support the Office of Sponsor and Regulatory Oversight within the NCI's Center for Cancer Research. The contract is a Blanket Purchase Agreement (BPA) Call issued under the Multiple Award Schedule (MAS) contract vehicle,...
This federal contract award, valued at $1,312,381.54, was issued by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract is for Clarity Project and Portfolio Management (PPM) software licenses, as well as technical support and maintenance services, in support of the Center for Biomedical Informatics and Information Technology (CBIIT) within NCI. The contract is a delivery order issued...
This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $5,261,900.00 contract is for the expansion of clinical trial data for The Cancer Imaging Archive (TCIA). The contract is a delivery order with a cost-plus-fixed-fee pricing type and a completion date of September 23, 2023. Leidos Biomedical Research has a broad Federally...
This is a sole source contract awarded by the Federal Trade Commission (FTC) to Caerus US 1 Inc., operating as Citeline, for a license to access Managed Markets Insight & Technology's (MMIT) Formulary Analytics data. The contract has a ceiling value of $247,500.00 and a performance period ending on September 13, 2024. The purpose is to support the FTC's Office of Policy Planning and Bureau of Economics in their research and analysis of pharmaceutical markets. The contract is a Definitive...
This federal contract award, valued at $515,959.35, was issued by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The award is for support services, including a Clinical Program Manager, for the Office of Sponsor & Regulatory Oversight (OSRO) within the Center for Cancer Research (CCR) at NCI. The contract is a Blanket Purchase Agreement (BPA) call under the Scientific Equipment and Services (FSS-66) Multiple Award Schedule...
The National Cancer Institute (NCI) awarded a $5,757,425.26 cost-plus-fixed-fee delivery order contract to Technical Resources International, Inc. (TRI) for Cancer Prevention Clinical Trials Auditing and Informatics Support. The contract has a performance period through May 15, 2024. TRI is a minority-owned, woman-owned, and Hispanic American-owned small business that specializes in providing comprehensive clinical research support services to federal health agencies. This contract is not set...